For research use only
| Cat No. | ABC-TC3938 |
| Product Type | Mouse Primary Cells |
| Cell Type | B Cell |
| Species | Mouse |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Spleen |
| Disease | Normal |
| Storage | Liquid Nitrogen |
Mouse spleen is dissociated into a single cell suspension.
Mouse Splenocytes CD19+ B Cells are isolated from the spleen tissue of healthy mice and positively selected for CD19 expression. These cells exhibit a characteristic round morphology in suspension culture. Functionally, CD19+ B cells play a central role in humoral immunity by producing antibodies, presenting antigens, and regulating immune responses, with dysregulation associated with autoimmune diseases like lupus and B-cell lymphomas. The cells express CD19. These primary B cells have limited proliferative capacity in vitro. Each lot undergoes rigorous screening and isolation procedures, and is rigorously tested to ensure it is free of contamination from Mycoplasma, Fungi, Yeast, and Bacteria.
| Product Code | Mouse Splenocytes CD19+ B Cells, Mouse CD19+ B Cells, Murine Splenic B Lymphocytes, CD19 Positive B Cells (Mouse) |
| Species | Mouse |
| Cat.No | ABC-TC3938 |
| Product Category | Primary Cells |
| Size/Quantity | 1 vial |
| Cell Type | B Cell |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Spleen |
| Disease | Normal |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Mouse Primary Cells |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
Mouse Splenocytes CD19+ B Cells can be used as an in vitro cell model to study the pathogenesis of autoimmune diseases, humoral immune disorders, and lymphoproliferative diseases, such as systemic lupus erythematosus (SLE), rheumatoid arthritis, and B-cell lymphoma, which enables researchers to investigate antibody secretion profiles, plasma cell differentiation kinetics, and responses to T-cell-derived signals and autoantigens. These studies yield valuable insights into the molecular pathways underlying B-cell dysfunction, and provide a better understanding of CD19+ B cells’ physiological roles in adaptive immunity and their pathological alterations in disease, supporting discovery research and molecular target identification for immune-mediated disorders and B-cell-related malignancies.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).